← Eichor
Condition: Maternal Exposure Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Maternal Exposure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium E
NA · 1 location(s) · Medical College of Wisconsin · NCT07274527
Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development
Phase N/A · 3 location(s) · Fundació Sant Joan de Déu · NCT07033663
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
Phase 1 · 1 location(s) · University of Colorado, Denver · NCT06379971
Maternal And Infant Antipsychotic Study
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06049953
Scottish Advanced Fetal Research Study
Phase N/A · 1 location(s) · University of Aberdeen · NCT04613583
A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteri
Phase N/A · 1 location(s) · Ascendis Pharma A/S · NCT07345494
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During P
Phase N/A · 4 location(s) · BioMarin Pharmaceutical · NCT05579548
PREG - Offspring: Investigation of Children From Mothers With and Without Gestational Diabetes
Phase N/A · 1 location(s) · University Hospital Tuebingen · NCT04722900
Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial
NA · 1 location(s) · University of Lausanne Hospitals · NCT05927324
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Phase N/A · 1 location(s) · The Task Force for Global Health · NCT05368974
Healing Circles: An Intervention for Canadian Indigenous Mothers & Children Affected by IPV
NA · 1 location(s) · University of Manitoba · NCT04235335
Optimizing Mental Health for Infants Exposed to Early Adversity: A Comparison of Breaking the Cycle and Maxxine Wright
NA · 2 location(s) · University of Ottawa · NCT05768815
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it Duri
Phase N/A · 1 location(s) · Biogen · NCT06628687
Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories
Phase N/A · 1 location(s) · University of Zimbabwe · NCT07195006
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxoli
Phase N/A · 1 location(s) · Incyte Corporation · NCT06259669
6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07146451
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women
Phase N/A · 5 location(s) · Chiesi Farmaceutici S.p.A. · NCT06941025
Early Life Feeding Exposure and Infant Immune and Health Status.
Phase N/A · 1 location(s) · University of Idaho · NCT05986539
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod Dur
Phase N/A · 4 location(s) · argenx · NCT06299748
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
Phase 4 · 1 location(s) · University of North Carolina, Chapel Hill · NCT06158126
The UFIM (Ultraprocessed Foods In Breast Milk) Project
Phase N/A · 1 location(s) · Federico II University · NCT05889520
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Phase N/A · 1 location(s) · Pfizer · NCT05046613
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy a
Phase N/A · 1 location(s) · Ipsen · NCT06258902
Bempedoic Acid Pregnancy Surveillance Program
Phase N/A · 1 location(s) · Esperion Therapeutics, Inc. · NCT05103254
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
Phase N/A · 2 location(s) · Jazz Pharmaceuticals · NCT06113237
In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics
Phase N/A · 1 location(s) · Columbia University · NCT07296107
Mycotoxins in Mothers Milk in Israel
Phase N/A · 1 location(s) · Assaf-Harofeh Medical Center · NCT05371106
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Phase N/A · 1 location(s) · Murdoch Childrens Research Institute · NCT05394363
CAVEAT: An Open-Trial Feasibility Study
NA · 1 location(s) · University of Lausanne Hospitals · NCT06552832
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.